Literature DB >> 23392898

Improving thrombolysis for acute ischemic stroke in Lombardia stroke centers.

A Cavallini1, E Tartara, S Marcheselli, E Agostoni, S Quaglini, G Micieli.   

Abstract

The purpose of this study is to identify which factors are able to limit or hamper the access to systemic thrombolysis (evTPA) in Lombardia to define corrective interventions. We analyzed 1,015 patients with ischemic stroke admitted to emergency departments (ED) participating to the Lombardia Stroke Unit Registry and eligible for evTPA; 303 (29.9%) patients were treated with evTPA (evTPA+ group) and 712 (70.1%) were not (evTPA- group). We collected case-mix and stroke care process variables.The evTPA+ group was characterized by a shorter ED arrival time, a greater neurological impairment, a more chance to be admitted to ED linked to comprehensive stroke center (CSC) and a shorter waiting time to access to diagnostic procedures. The chance to be treated with evTPA was greater if neurological evaluation anticipated neuroimaging (p = 0.0003). The multivariate analysis confirmed that the admission to ED linked to CSC (OR: 2.50, 95% CI: 1.39-4.48, p < 0.0001) and neurological evaluation performed before neuroimaging (OR: 2.34, 95% CI: 1.35-4.04, p = 0.002) increased the probability to receive rtPA. The evTPA treatment is strictly dependent on pre-hospital and ED care process phases and strongly influenced by the degree of stroke severity. Door-to-needle time is shorter in patients with a greater stroke severity and a shorter ED arrival time. A 24-h/week availability of the neurologist in ED can increase the percentage of thrombolysis optimizing the selection of patients and the timing of the diagnostic procedures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392898     DOI: 10.1007/s10072-013-1320-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  30 in total

Review 1.  Part 11: adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Edward C Jauch; Brett Cucchiara; Opeolu Adeoye; William Meurer; Jane Brice; Yvonne Yu-Feng Chan; Nina Gentile; Mary Fran Hazinski
Journal:  Circulation       Date:  2010-11-02       Impact factor: 29.690

2.  Reliability of the modified Rankin Scale.

Authors:  J P Burn
Journal:  Stroke       Date:  1992-03       Impact factor: 7.914

3.  Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program.

Authors:  Natalia S Rost; Eric E Smith; Muhammad A Pervez; Philip Mello; Paul Dreyer; Lee H Schwamm
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-04-24

4.  Stroke incidence and usage rate of thrombolysis in a Japanese urban city: the Kurashiki stroke registry.

Authors:  Yasuyuki Iguchi; Kazumi Kimura; Keiichi Sone; Hiroshi Miura; Hiroshi Endo; Sen Yamagata; Hisashi Koide; Kenji Suzuki; Tomoichiro Kimura; Masaru Sakurai; Nobuya Mishima; Kenji Yoshii; Hiroyuki Fujisawa; Sunao Ebisutani
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-11-02       Impact factor: 2.136

5.  Interrater reliability of the NIH stroke scale.

Authors:  L B Goldstein; C Bertels; J N Davis
Journal:  Arch Neurol       Date:  1989-06

6.  Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?

Authors:  Ameer E Hassan; Haralabos Zacharatos; Bahareh Hassanzadeh; Ahmed El-Gengaihy; Ammar AlKawi; Akram Shhadeh; Jawad F Kirmani
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-03       Impact factor: 2.136

Review 7.  Telestroke increases use of acute stroke therapy.

Authors:  Peter Müller-Barna; Lee H Schwamm; Roman L Haberl
Journal:  Curr Opin Neurol       Date:  2012-02       Impact factor: 5.710

8.  Thrombolysis for acute ischemic stroke in Joint Commission-certified and -noncertified hospitals in Michigan.

Authors:  Kumar Rajamani; Scott Millis; Sam Watson; Flicia Mada; Leeza Salowich-Palm; Sabrina Hinton; Seemant Chaturvedi
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-01       Impact factor: 2.136

9.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

10.  Thrombolysis in patients with marked clinical fluctuations in neurologic status due to cerebral ischemia.

Authors:  Ozcan Ozdemir; Vadim Beletsky; Richard Chan; Vladimir Hachinski
Journal:  Arch Neurol       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.